Skip to content

Loading page…

Original disclosures.
Open access.

Evidence for better research and decisions.

Follow our research

Database

Sustainability reports
Countries
Exchanges
Sectors
Industries
Years
Statistics

Services

Reports
Packages
Solutions
Markdown
Enterprise licence
Coverage assurance
Download portal

About

About us
Clients
Research & news
Careers

Resources

Pricing
Questions & answers
API documentation
Contact
Become a Supporter

© 2026 SustainabilityReports.com. All rights reserved.

Privacy policy Terms of service

BioInvent International AB 2024 Annual Report with Sustainability Disclosures

Company: BioInvent International AB

Sector: Professional & technical services

Country: Sweden

Year: 2024

Type: Annual Report with Sustainability Disclosures

Pages: 84

Home
BioInvent International AB
2024 Annual Report with Sustainability Disclosures

BioInvent International AB

Annual Report

Preview not available

Report overview

The report highlights BioInvent's clinical progress in 2024, with six clinical-stage programs and encouraging responses across BI-1808, BI-1206 and BT-001. It also records the company's ISO 26000 verification as a step forward in ESG work. Group net sales were SEK 44.7 million, mainly from antibody production and research services, and year-end employment was 114 FTE.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Publication date: 4 April 2025
Language
Pages
File size

Standards & Assurance

Standards

Other

Assurance

Statement included

ESG & Materiality

ESG data

Indicators available in this report:

Employees

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services